Enhabit Stock Price, News & Analysis

Enhabit, Inc. (NYSE: EHAB) announced its participation in the Credit Suisse 31st Annual Healthcare Conference in Palos Verdes, California, on November 8, 2022. President and CEO Barbara Jacobsmeyer, along with CFO Crissy Carlisle, will engage in a fireside chat at 5:00 p.m. ET. This session will be available via a live webcast on the company's investor relations website. Enhabit is a prominent home health and hospice provider, operating 250 home health and 100 hospice locations across 34 states, aiming to enhance patient care at home.

Enhabit, Inc. (NYSE: EHAB) reported its third quarter 2022 results, showing a 3.0% decline in net service revenue to $265.7 million compared to Q3 2021, and a significant 60.2% drop in net income to $8.6 million. Adjusted EBITDA fell 26.3% to $31.7 million. Home health services experienced growth, particularly in Medicare Advantage admissions, up 31.5% year-over-year. However, the company faces challenges from increased labor costs, a shift to non-episodic patients, and lower hospice volumes. Full-year guidance for net service revenue and adjusted EBITDA has been adjusted downward.

Enhabit, Inc. (NYSE: EHAB) will report its third-quarter results for the period ending September 30, 2022, after market close on November 1, 2022. A conference call will be held on November 2, 2022, at 10:00 a.m. Eastern to discuss the results. Interested participants can join by dialing 888-660-6150 (toll-free) or 929-203-0843 (international), with Conference ID: 5248158. The call can be accessed online via Enhabit's investor website.

Enhabit, Inc. (NYSE: EHAB) has acquired Caring Hearts Hospice, a local provider in Texas, effective October 1, 2022. This acquisition enhances Enhabit’s hospice service line by adding four new locations: Gun Barrel City, Mineola, Palestine, and Quinlan, Texas. The company, which ranks as the fourth largest Medicare-certified home health provider and the 12th largest hospice provider in the U.S., aims to expand its national footprint and improve patient care quality.

Enhabit Home Health & Hospice (NYSE: EHAB) announced its participation in key investor events, including the Jefferies Nashville Bus Tour on Aug. 31, 2022, and the Wells Fargo Healthcare Conference in Boston on Sept. 8, 2022. CEO Barbara Jacobsmeyer and CFO Crissy Carlisle will host a fireside chat on Sept. 8 at 4:20 p.m. ET, available via live webcast on their investor page. Enhabit operates 251 home health and 100 hospice locations across 34 states, focusing on innovative patient care solutions.

Enhabit Home Health & Hospice (NYSE: EHAB) reported a 6.3% decline in net service revenue to $268.0 million for Q2 2022, compared to Q2 2021. Net income fell 37.8% to $20.1 million. Adjusted EBITDA decreased 30.3% to $40.3 million, reflecting challenges in the healthcare sector, including labor costs and a shift to non-episodic payor mix. The company revised its full-year guidance, projecting net service revenue between $1,075 to $1,110 million and adjusted EBITDA between $155 to $170 million.

Enhabit Home Health & Hospice (NYSE: EHAB) announced it will report its second-quarter results for the period ending June 30, 2022, after market hours on August 1, 2022. The company will hold its first investor conference call as a publicly traded entity on August 2, 2022, at 11 a.m. ET. Investors can access the call by dialing 888-660-6150 with conference ID 5248158. A live webcast and replay will be available on the company's investor website. Enhabit operates 252 home health and 99 hospice locations across 34 states, focusing on patient-centered care.

Enhabit Home Health & Hospice has successfully completed its spin-off from Encompass Health Corporation, now trading under the ticker symbol EHAB on the NYSE as of July 1, 2022. The company emphasizes its commitment to providing high-quality in-home patient care while leveraging over 20 years of expertise. It operates across 351 locations in 34 states. Additionally, Enhabit appointed Tina L. Brown-Stevenson and Susan A. La Monica to its board, enhancing strategic capabilities. The spin-off allows for greater operational flexibility and focus on patient and investor interests.

Encompass Health Corporation has successfully completed the spin-off of its home health and hospice business, Enhabit, Inc., as of July 1, 2022. Each Encompass Health stockholder received one share of Enhabit common stock for every two shares held by the close of business on June 24, 2022. This transaction is structured to be tax-free for shareholders, except for cash received for fractional shares. Enhabit will begin trading on the NYSE under the symbol 'EHAB,' while Encompass Health continues to trade under 'EHC.'